EMEA (Europe, Middle East and Africa) Mantle Cell Lymphoma Treatment Market Report 2018

January 2018 | 113 pages | ID: E2499B9AF10EN
QYResearch

Abstracts

In this report, the EMEA Mantle Cell Lymphoma Treatment market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Mantle Cell Lymphoma Treatment for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Mantle Cell Lymphoma Treatment market competition by top manufacturers/players, with Mantle Cell Lymphoma Treatment sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Astex Pharmaceuticals, Inc.
• Bayer AG
• Bristol-Myers Squibb Company
• Celgene Corporation
• Cellular Biomedicine Group, Inc.
• Eisai
• EpiZyme, Inc.
• Fate Therapeutics, Inc.
• Genentech, Inc.
• Gilead Sciences, Inc.
• GlaxoSmithKline Plc
• Hutchison MediPharma Limited
• ImmunoGen, Inc.
• Immunomedics, Inc.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Acalabrutinib
• JCAR-017
• JNJ-64052781
• Acalisib
• IGN-002
• IMGN-529
• AFM-11
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Mantle Cell Lymphoma Treatment Market Report 2018

1 MANTLE CELL LYMPHOMA TREATMENT OVERVIEW

1.1 Product Overview and Scope of Mantle Cell Lymphoma Treatment
1.2 Classification of Mantle Cell Lymphoma Treatment
  1.2.1 EMEA Mantle Cell Lymphoma Treatment Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Mantle Cell Lymphoma Treatment Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Acalabrutinib
  1.2.4 JCAR-017
  1.2.5 JNJ-64052781
  1.2.6 Acalisib
  1.2.7 IGN-002
  1.2.8 IMGN-529
  1.2.9 AFM-11
  1.2.10 Others
1.3 EMEA Mantle Cell Lymphoma Treatment Market by Application/End Users
  1.3.1 EMEA Mantle Cell Lymphoma Treatment Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 EMEA Mantle Cell Lymphoma Treatment Market by Region
  1.4.1 EMEA Mantle Cell Lymphoma Treatment Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Mantle Cell Lymphoma Treatment (2013-2025)
  1.5.1 EMEA Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2013-2025)

2 EMEA MANTLE CELL LYMPHOMA TREATMENT COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Mantle Cell Lymphoma Treatment Market Competition by Players/Manufacturers
  2.1.1 EMEA Mantle Cell Lymphoma Treatment Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Mantle Cell Lymphoma Treatment Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Mantle Cell Lymphoma Treatment Sale Price by Players (2013-2018)
2.2 EMEA Mantle Cell Lymphoma Treatment (Volume and Value) by Type/Product Category
  2.2.1 EMEA Mantle Cell Lymphoma Treatment Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Mantle Cell Lymphoma Treatment Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Mantle Cell Lymphoma Treatment Sale Price by Type (2013-2018)
2.3 EMEA Mantle Cell Lymphoma Treatment (Volume) by Application
2.4 EMEA Mantle Cell Lymphoma Treatment (Volume and Value) by Region
  2.4.1 EMEA Mantle Cell Lymphoma Treatment Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Mantle Cell Lymphoma Treatment Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Mantle Cell Lymphoma Treatment Sales Price by Region (2013-2018)

3 EUROPE MANTLE CELL LYMPHOMA TREATMENT (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Mantle Cell Lymphoma Treatment Sales and Value (2013-2018)
  3.1.1 Europe Mantle Cell Lymphoma Treatment Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2013-2018)
3.2 Europe Mantle Cell Lymphoma Treatment Sales and Market Share by Type
3.3 Europe Mantle Cell Lymphoma Treatment Sales and Market Share by Application
3.4 Europe Mantle Cell Lymphoma Treatment Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Mantle Cell Lymphoma Treatment Sales Volume by Countries (2013-2018)
  3.4.2 Europe Mantle Cell Lymphoma Treatment Revenue by Countries (2013-2018)
  3.4.3 Germany Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)
  3.4.4 France Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)
  3.4.5 UK Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)
  3.4.6 Russia Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)
  3.4.7 Italy Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)

4 MIDDLE EAST MANTLE CELL LYMPHOMA TREATMENT (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Mantle Cell Lymphoma Treatment Sales and Value (2013-2018)
  4.1.1 Middle East Mantle Cell Lymphoma Treatment Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2013-2018)
4.2 Middle East Mantle Cell Lymphoma Treatment Sales and Market Share by Type
4.3 Middle East Mantle Cell Lymphoma Treatment Sales and Market Share by Application
4.4 Middle East Mantle Cell Lymphoma Treatment Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Mantle Cell Lymphoma Treatment Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Mantle Cell Lymphoma Treatment Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)
  4.4.4 Israel Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)
  4.4.5 UAE Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)
  4.4.6 Iran Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)

5 AFRICA MANTLE CELL LYMPHOMA TREATMENT (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Mantle Cell Lymphoma Treatment Sales and Value (2013-2018)
  5.1.1 Africa Mantle Cell Lymphoma Treatment Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2013-2018)
5.2 Africa Mantle Cell Lymphoma Treatment Sales and Market Share by Type
5.3 Africa Mantle Cell Lymphoma Treatment Sales and Market Share by Application
5.4 Africa Mantle Cell Lymphoma Treatment Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Mantle Cell Lymphoma Treatment Sales Volume by Countries (2013-2018)
  5.4.2 Africa Mantle Cell Lymphoma Treatment Revenue by Countries (2013-2018)
  5.4.3 South Africa Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Mantle Cell Lymphoma Treatment Sales and Growth Rate (2013-2018)

6 EMEA MANTLE CELL LYMPHOMA TREATMENT MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Astex Pharmaceuticals, Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Mantle Cell Lymphoma Treatment Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Bayer AG
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Mantle Cell Lymphoma Treatment Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer AG Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Bristol-Myers Squibb Company
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Mantle Cell Lymphoma Treatment Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Celgene Corporation
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Mantle Cell Lymphoma Treatment Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Celgene Corporation Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Cellular Biomedicine Group, Inc.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Mantle Cell Lymphoma Treatment Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Eisai
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Mantle Cell Lymphoma Treatment Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Eisai Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 EpiZyme, Inc.
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Mantle Cell Lymphoma Treatment Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Fate Therapeutics, Inc.
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Mantle Cell Lymphoma Treatment Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Genentech, Inc.
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Mantle Cell Lymphoma Treatment Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Genentech, Inc. Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Gilead Sciences, Inc.
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Mantle Cell Lymphoma Treatment Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 GlaxoSmithKline Plc
6.12 Hutchison MediPharma Limited
6.13 ImmunoGen, Inc.
6.14 Immunomedics, Inc.

7 MANTLE CELL LYMPHOMA TREATMENT MANUFACTURING COST ANALYSIS

7.1 Mantle Cell Lymphoma Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Mantle Cell Lymphoma Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Mantle Cell Lymphoma Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Mantle Cell Lymphoma Treatment Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA MANTLE CELL LYMPHOMA TREATMENT MARKET FORECAST (2018-2025)

11.1 EMEA Mantle Cell Lymphoma Treatment Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Mantle Cell Lymphoma Treatment Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Mantle Cell Lymphoma Treatment Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Mantle Cell Lymphoma Treatment Price and Trend Forecast (2018-2025)
11.2 EMEA Mantle Cell Lymphoma Treatment Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Mantle Cell Lymphoma Treatment Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Mantle Cell Lymphoma Treatment Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Mantle Cell Lymphoma Treatment Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Mantle Cell Lymphoma Treatment Sales Forecast by Type (2018-2025)
11.7 EMEA Mantle Cell Lymphoma Treatment Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Mantle Cell Lymphoma Treatment
Figure EMEA Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Type (2013-2025)
Figure EMEA Mantle Cell Lymphoma Treatment Sales Volume Market Share by Type (Product Category) in 2017
Figure Acalabrutinib Product Picture
Figure JCAR-017 Product Picture
Figure JNJ-64052781 Product Picture
Figure Acalisib Product Picture
Figure IGN-002 Product Picture
Figure IMGN-529 Product Picture
Figure AFM-11 Product Picture
Figure Others Product Picture
Figure EMEA Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Application (2013-2025)
Figure EMEA Sales Market Share of Mantle Cell Lymphoma Treatment by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Mantle Cell Lymphoma Treatment Market Size (Million USD) by Region (2013-2025)
Figure Europe Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Mantle Cell Lymphoma Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Mantle Cell Lymphoma Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Africa Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Mantle Cell Lymphoma Treatment Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Mantle Cell Lymphoma Treatment Sales Volume and Growth Rate (2013-2025)
Figure EMEA Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Mantle Cell Lymphoma Treatment Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table EMEA Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) of Major Players (2013-2018)
Table EMEA Mantle Cell Lymphoma Treatment Sales Share by Players (2013-2018)
Figure 2017 Mantle Cell Lymphoma Treatment Sales Share by Players
Figure 2017 Mantle Cell Lymphoma Treatment Sales Share by Players
Figure EMEA Mantle Cell Lymphoma Treatment Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Mantle Cell Lymphoma Treatment Revenue (Million USD) by Players (2013-2018)
Table EMEA Mantle Cell Lymphoma Treatment Revenue Share by Players (2013-2018)
Table 2017 EMEA Mantle Cell Lymphoma Treatment Revenue Share by Players
Table 2017 EMEA Mantle Cell Lymphoma Treatment Revenue Share by Players
Table EMEA Mantle Cell Lymphoma Treatment Sale Price (USD/Pcs) by Players (2013-2018)
Table EMEA Mantle Cell Lymphoma Treatment Sales (K Pcs) and Market Share by Type (2013-2018)
Table EMEA Mantle Cell Lymphoma Treatment Sales Share by Type (2013-2018)
Figure Sales Market Share of Mantle Cell Lymphoma Treatment by Type (2013-2018)
Figure EMEA Mantle Cell Lymphoma Treatment Sales Market Share by Type (2013-2018)
Table EMEA Mantle Cell Lymphoma Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Mantle Cell Lymphoma Treatment Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Mantle Cell Lymphoma Treatment by Type in 2017
Table EMEA Mantle Cell Lymphoma Treatment Sale Price (USD/Pcs) by Type (2013-2018)
Table EMEA Mantle Cell Lymphoma Treatment Sales (K Pcs) and Market Share by Application (2013-2018)
Table EMEA Mantle Cell Lymphoma Treatment Sales Share by Application (2013-2018)
Figure Sales Market Share of Mantle Cell Lymphoma Treatment by Application (2013-2018)
Figure EMEA Mantle Cell Lymphoma Treatment Sales Market Share by Application in 2017
Table EMEA Mantle Cell Lymphoma Treatment Sales (K Pcs) and Market Share by Region (2013-2018)
Table EMEA Mantle Cell Lymphoma Treatment Sales Share by Region (2013-2018)
Figure Sales Market Share of Mantle Cell Lymphoma Treatment by Region (2013-2018)
Figure EMEA Mantle Cell Lymphoma Treatment Sales Market Share in 2017
Table EMEA Mantle Cell Lymphoma Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Mantle Cell Lymphoma Treatment Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Mantle Cell Lymphoma Treatment by Region (2013-2018)
Figure EMEA Mantle Cell Lymphoma Treatment Revenue Market Share Regions in 2017
Table EMEA Mantle Cell Lymphoma Treatment Sales Price (USD/Pcs) by Region (2013-2018)
Figure Europe Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2013-2018)
Table Europe Mantle Cell Lymphoma Treatment Sales (K Pcs) by Type (2013-2018)
Table Europe Mantle Cell Lymphoma Treatment Market Share by Type (2013-2018)
Figure Europe Mantle Cell Lymphoma Treatment Market Share by Type in 2017
Table Europe Mantle Cell Lymphoma Treatment Sales (K Pcs) by Application (2013-2018)
Table Europe Mantle Cell Lymphoma Treatment Market Share by Application (2013-2018)
Figure Europe Mantle Cell Lymphoma Treatment Market Share by Application in 2017
Table Europe Mantle Cell Lymphoma Treatment Sales (K Pcs) by Countries (2013-2018)
Table Europe Mantle Cell Lymphoma Treatment Sales Market Share by Countries (2013-2018)
Figure Europe Mantle Cell Lymphoma Treatment Sales Market Share by Countries (2013-2018)
Figure Europe Mantle Cell Lymphoma Treatment Sales Market Share by Countries in 2017
Table Europe Mantle Cell Lymphoma Treatment Revenue (Million USD) by Countries (2013-2018)
Table Europe Mantle Cell Lymphoma Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Mantle Cell Lymphoma Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Mantle Cell Lymphoma Treatment Revenue Market Share by Countries in 2017
Figure Germany Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure France Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure UK Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Russia Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Italy Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Benelux Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Mantle Cell Lymphoma Treatment Sales (K Pcs) by Type (2013-2018)
Table Middle East Mantle Cell Lymphoma Treatment Market Share by Type (2013-2018)
Figure Middle East Mantle Cell Lymphoma Treatment Market Share by Type (2013-2018)
Table Middle East Mantle Cell Lymphoma Treatment Sales (K Pcs) by Applications (2013-2018)
Table Middle East Mantle Cell Lymphoma Treatment Market Share by Applications (2013-2018)
Figure Middle East Mantle Cell Lymphoma Treatment Sales Market Share by Application in 2017
Table Middle East Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Countries (2013-2018)
Table Middle East Mantle Cell Lymphoma Treatment Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Mantle Cell Lymphoma Treatment Sales Volume Market Share by Countries in 2017
Table Middle East Mantle Cell Lymphoma Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East Mantle Cell Lymphoma Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East Mantle Cell Lymphoma Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East Mantle Cell Lymphoma Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Israel Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure UAE Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Iran Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Mantle Cell Lymphoma Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Mantle Cell Lymphoma Treatment Sales (K Pcs) by Type (2013-2018)
Table Africa Mantle Cell Lymphoma Treatment Sales Market Share by Type (2013-2018)
Figure Africa Mantle Cell Lymphoma Treatment Sales Market Share by Type (2013-2018)
Figure Africa Mantle Cell Lymphoma Treatment Sales Market Share by Type in 2017
Table Africa Mantle Cell Lymphoma Treatment Sales (K Pcs) by Application (2013-2018)
Table Africa Mantle Cell Lymphoma Treatment Sales Market Share by Application (2013-2018)
Figure Africa Mantle Cell Lymphoma Treatment Sales Market Share by Application (2013-2018)
Table Africa Mantle Cell Lymphoma Treatment Sales Volume (K Pcs) by Countries (2013-2018)
Table Africa Mantle Cell Lymphoma Treatment Sales Market Share by Countries (2013-2018)
Figure Africa Mantle Cell Lymphoma Treatment Sales Market Share by Countries (2013-2018)
Figure Africa Mantle Cell Lymphoma Treatment Sales Market Share by Countries in 2017
Table Africa Mantle Cell Lymphoma Treatment Revenue (Million USD) by Countries (2013-2018)
Table Africa Mantle Cell Lymphoma Treatment Revenue Market Share by Countries (2013-2018)
Figure Africa Mantle Cell Lymphoma Treatment Revenue Market Share by Countries (2013-2018)
Figure Africa Mantle Cell Lymphoma Treatment Revenue Market Share by Countries in 2017
Figure South Africa Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Nigeria Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Egypt Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Algeria Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Table Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Basic Information List
Table Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Sales Market Share in EMEA (2013-2018)
Figure Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Revenue Market Share in EMEA (2013-2018)
Table Bayer AG Mantle Cell Lymphoma Treatment Basic Information List
Table Bayer AG Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bayer AG Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Bayer AG Mantle Cell Lymphoma Treatment Sales Market Share in EMEA (2013-2018)
Figure Bayer AG Mantle Cell Lymphoma Treatment Revenue Market Share in EMEA (2013-2018)
Table Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Basic Information List
Table Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Sales Market Share in EMEA (2013-2018)
Figure Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Revenue Market Share in EMEA (2013-2018)
Table Celgene Corporation Mantle Cell Lymphoma Treatment Basic Information List
Table Celgene Corporation Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Celgene Corporation Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Celgene Corporation Mantle Cell Lymphoma Treatment Sales Market Share in EMEA (2013-2018)
Figure Celgene Corporation Mantle Cell Lymphoma Treatment Revenue Market Share in EMEA (2013-2018)
Table Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Basic Information List
Table Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Sales Market Share in EMEA (2013-2018)
Figure Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Revenue Market Share in EMEA (2013-2018)
Table Eisai Mantle Cell Lymphoma Treatment Basic Information List
Table Eisai Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eisai Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Eisai Mantle Cell Lymphoma Treatment Sales Market Share in EMEA (2013-2018)
Figure Eisai Mantle Cell Lymphoma Treatment Revenue Market Share in EMEA (2013-2018)
Table EpiZyme, Inc. Mantle Cell Lymphoma Treatment Basic Information List
Table EpiZyme, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure EpiZyme, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure EpiZyme, Inc. Mantle Cell Lymphoma Treatment Sales Market Share in EMEA (2013-2018)
Figure EpiZyme, Inc. Mantle Cell Lymphoma Treatment Revenue Market Share in EMEA (2013-2018)
Table Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Basic Information List
Table Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Sales Market Share in EMEA (2013-2018)
Figure Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Revenue Market Share in EMEA (2013-2018)
Table Genentech, Inc. Mantle Cell Lymphoma Treatment Basic Information List
Table Genentech, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genentech, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Genentech, Inc. Mantle Cell Lymphoma Treatment Sales Market Share in EMEA (2013-2018)
Figure Genentech, Inc. Mantle Cell Lymphoma Treatment Revenue Market Share in EMEA (2013-2018)
Table Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Basic Information List
Table Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Sales Market Share in EMEA (2013-2018)
Figure Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Revenue Market Share in EMEA (2013-2018)
Table GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Basic Information List
Table Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Basic Information List
Table ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Basic Information List
Table Immunomedics, Inc. Mantle Cell Lymphoma Treatment Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Mantle Cell Lymphoma Treatment
Figure Manufacturing Process Analysis of Mantle Cell Lymphoma Treatment
Figure Mantle Cell Lymphoma Treatment Industrial Chain Analysis
Table Raw Materials Sources of Mantle Cell Lymphoma Treatment Major Manufacturers in 2017
Table Major Buyers of Mantle Cell Lymphoma Treatment
Table Distributors/Traders List
Figure EMEA Mantle Cell Lymphoma Treatment Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure EMEA Mantle Cell Lymphoma Treatment Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Mantle Cell Lymphoma Treatment Price (USD/Pcs) and Trend Forecast (2018-2025)
Table EMEA Mantle Cell Lymphoma Treatment Sales (K Pcs) Forecast by Region (2018-2025)
Figure EMEA Mantle Cell Lymphoma Treatment Sales Market Share Forecast by Region (2018-2025)
Table EMEA Mantle Cell Lymphoma Treatment Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Mantle Cell Lymphoma Treatment Revenue Market Share Forecast by Region (2018-2025)
Table Europe Mantle Cell Lymphoma Treatment Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Europe Mantle Cell Lymphoma Treatment Sales Market Share Forecast by Countries (2018-2025)
Table Europe Mantle Cell Lymphoma Treatment Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Mantle Cell Lymphoma Treatment Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Mantle Cell Lymphoma Treatment Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Middle East Mantle Cell Lymphoma Treatment Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Mantle Cell Lymphoma Treatment Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Mantle Cell Lymphoma Treatment Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Mantle Cell Lymphoma Treatment Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Africa Mantle Cell Lymphoma Treatment Sales Market Share Forecast by Countries (2018-2025)
Table Africa Mantle Cell Lymphoma Treatment Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Mantle Cell Lymphoma Treatment Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Mantle Cell Lymphoma Treatment Sales (K Pcs) Forecast by Type (2018-2025)
Figure EMEA Mantle Cell Lymphoma Treatment Sales Market Share Forecast by Type (2018-2025)
Table EMEA Mantle Cell Lymphoma Treatment Sales (K Pcs) Forecast by Application (2018-2025)
Figure EMEA Mantle Cell Lymphoma Treatment Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources